Characterization of Endothelial Cells Associated with Cerebral Arteriovenous Malformation

Yu-Chen Jia1, Jia-Yue Fu2, Ping Huang3

  • 1Inner Mongolia Key Laboratory of Molecular Biology, School of Basic Medical Sciences, Inner Mongolia Medical University, Hohhot, People's Republic of China.

Insights

Vascular endothelial cells (ECs) from cerebral arteriovenous malformations (cAVMs) show enhanced proliferation and migration. These arterialized vein ECs (AV-ECs) present potential therapeutic targets for treating cAVMs.

Area of Science:

  • Vascular Biology
  • Pathophysiology
  • Regenerative Medicine

Background:

  • Cerebral arteriovenous malformation (cAVM) involves complex angiogenesis and vein remodeling.
  • The specific role and changes in vascular endothelial cells (ECs) during cAVM development are not fully understood.

Purpose of the Study:

  • To investigate the morphological and functional characteristics of ECs in the context of cAVM.
  • To determine if ECs from cAVMs exhibit altered properties compared to normal ECs.

Main Methods:

  • Established a rat model of cAVM by creating an arteriovenous fistula.
  • Utilized digital subtraction angiography (DSA), histology, and immunohistochemistry for model evaluation.
  • Isolated and characterized endothelial cells (ECs) from both cAVM and control rats using MTT, cell scratch, and tube formation assays.
  • Quantified vascular endothelial growth factor (VEGF) secretion via ELISA.

Main Results:

  • The cAVM rat model displayed characteristic pathological features.
  • Endothelial cells from arterialized veins (AV-ECs) demonstrated significantly enhanced proliferation, migration, and tube formation capabilities compared to normal vein ECs (NV-ECs).
  • AV-ECs secreted significantly higher levels of VEGF than NV-ECs.

Conclusions:

  • Endothelial cells isolated from the cAVM rat model exhibit increased proliferative, migratory, and angiogenic potential.
  • These AV-ECs represent a potential therapeutic target for cAVM treatment.
Abstract